非感染性葡萄膜炎：优化治疗依从性和坚持性的策略
Noninfectious uveitis: strategies to optimize treatment compliance and adherence.
作者信息
Dolz-Marco Rosa, Gallego-Pinazo Roberto, Díaz-Llopis Manuel, Cunningham Emmett T, Arévalo J Fernando
机构信息
Unit of Macula, Department of Ophthalmology, University and Polytechnic Hospital La Fe, Spain.
Faculty of Medicine, University of Valencia, Spain.
出版信息
Clin Ophthalmol. 2015 Aug 18;9:1477-81. doi: 10.2147/OPTH.S36650. eCollection 2015.
Abstract
Noninfectious uveitis includes a heterogenous group of sight-threatening ocular and systemic disorders. Significant progress has been made in the treatment of noninfectious uveitis in recent years, particularly with regard to the effective use of corticosteroids and non-corticosteroid immunosuppressive drugs, including biologic agents. All of these therapeutic approaches are limited, however, by any given patient's ability to comply with and adhere to their prescribed treatment. In fact, compliance and adherence are among the most important patient-related determinants of treatment success. We discuss strategies to optimize compliance and adherence.
摘要
非感染性葡萄膜炎包括一组异质性的、威胁视力的眼部和全身性疾病。近年来，非感染性葡萄膜炎的治疗取得了显著进展，特别是在有效使用皮质类固醇和非皮质类固醇免疫抑制药物（包括生物制剂）方面。然而，所有这些治疗方法都受到任何特定患者遵守和坚持规定治疗能力的限制。事实上，依从性和坚持性是治疗成功最重要的与患者相关的决定因素之一。我们讨论优化依从性和坚持性的策略。
相似文献
1
Noninfectious uveitis: strategies to optimize treatment compliance and adherence.非感染性葡萄膜炎：优化治疗依从性和坚持性的策略
Clin Ophthalmol. 2015 Aug 18;9:1477-81. doi: 10.2147/OPTH.S36650. eCollection 2015.
2
Recommendation of using systemic anti-tumor necrosis factor-alpha for the treatment of noninfectious uveitis in Taiwan.台湾关于使用全身性抗肿瘤坏死因子-α治疗非感染性葡萄膜炎的建议。
Taiwan J Ophthalmol. 2018 Jul-Sep;8(3):117-120. doi: 10.4103/tjo.tjo_32_18.
3
Intravitreal Sirolimus for the Treatment of Noninfectious Uveitis: Evolution through Preclinical and Clinical Studies.玻璃体内注射西罗莫司治疗非感染性葡萄膜炎：临床前和临床研究的进展。
Ophthalmology. 2018 Dec;125(12):1984-1993. doi: 10.1016/j.ophtha.2018.06.015. Epub 2018 Jul 27.
4
Systemic immunosuppressive therapies for uveitis in developing countries.发展中国家葡萄膜炎的全身免疫抑制疗法。
Indian J Ophthalmol. 2020 Sep;68(9):1852-1862. doi: 10.4103/ijo.IJO_1548_20.
5
A comprehensive review and update on the non-biologic treatment of adult noninfectious uveitis: part I.成人非感染性葡萄膜炎非生物治疗的全面综述与更新：第一部分。
Expert Opin Pharmacother. 2014 Oct;15(15):2141-54. doi: 10.1517/14656566.2014.948417.
6
Initial evaluation of subcutaneous daclizumab treatments for noninfectious uveitis: a multicenter noncomparative interventional case series.皮下注射达克珠单抗治疗非感染性葡萄膜炎的初步评估：一项多中心非对照干预性病例系列研究
Ophthalmology. 2005 May;112(5):764-70. doi: 10.1016/j.ophtha.2004.12.034.
7
Practical approach to the use of corticosteroids in patients with uveitis.实用方法在葡萄膜炎患者中使用皮质类固醇。
Can J Ophthalmol. 2010 Aug;45(4):352-8. doi: 10.3129/i10-081.
8
A systematic review of biologics for the treatment of noninfectious uveitis.生物制剂治疗非感染性葡萄膜炎的系统评价。
Immunotherapy. 2013 Jan;5(1):91-102. doi: 10.2217/imt.12.134.
9
A comprehensive review and update on the biologic treatment of adult noninfectious uveitis: part II.成人非感染性葡萄膜炎生物治疗的全面综述与更新：第二部分。
Expert Opin Biol Ther. 2014 Nov;14(11):1651-66. doi: 10.1517/14712598.2014.947957. Epub 2014 Sep 16.
10
Emerging drugs for the treatment of noninfectious uveitis.新兴药物治疗非感染性葡萄膜炎。
Expert Opin Emerg Drugs. 2019 Sep;24(3):173-190. doi: 10.1080/14728214.2019.1663823. Epub 2019 Sep 19.
引用本文的文献
1
Monoclonal Antibodies for the Treatment of Ocular Diseases.用于治疗眼部疾病的单克隆抗体
J Clin Med. 2024 Sep 28;13(19):5815. doi: 10.3390/jcm13195815.
2
Ocular immunosuppressive microenvironment and novel drug delivery for control of uveitis.眼免疫抑制微环境和新型药物传递系统用于控制葡萄膜炎。
Adv Drug Deliv Rev. 2023 Jul;198:114869. doi: 10.1016/j.addr.2023.114869. Epub 2023 May 10.
3
Outcomes of adalimumab therapy in refractory punctate inner choroidopathy and multifocal choroiditis.阿达木单抗治疗难治性点状内层脉络膜病变和多灶性脉络膜炎的疗效
Graefes Arch Clin Exp Ophthalmol. 2022 Jun;260(6):2013-2021. doi: 10.1007/s00417-021-05539-9. Epub 2022 Jan 4.
4
Signature of Circulating Biomarkers in Recurrent Non-Infectious Anterior Uveitis. Immunomodulatory Effects of DHA-Triglyceride. A Pilot Study.复发性非感染性前葡萄膜炎中循环生物标志物的特征。二十二碳六烯酸甘油三酯的免疫调节作用。一项初步研究。
Diagnostics (Basel). 2021 Apr 19;11(4):724. doi: 10.3390/diagnostics11040724.
5
Improving quick and accurate diagnosis of childhood JIA-uveitis from a pediatric rheumatology perspective.从儿科风湿病学角度改善儿童幼年特发性关节炎性葡萄膜炎的快速准确诊断。
Expert Rev Ophthalmol. 2020;15(2):101-109. doi: 10.1080/17469899.2020.1739521. Epub 2020 Mar 12.
6
Effectiveness of long-term infliximab use and impact of treatment adherence on disease control in refractory, non-infectious pediatric uveitis.长期使用英夫利昔单抗治疗难治性非感染性小儿葡萄膜炎的疗效及治疗依从性对疾病控制的影响。
Pediatr Rheumatol Online J. 2019 Nov 29;17(1):79. doi: 10.1186/s12969-019-0383-9.
本文引用的文献
1
[Factors associated with adherence to immunosuppressive therapy among transplant recipients].[移植受者中与免疫抑制治疗依从性相关的因素]
Hu Li Za Zhi. 2014 Aug;61(4):21-5. doi: 10.6224/JN.61.4.21.
2
Novel Intraocular Therapy in Non-infectious Uveitis of the Posterior Segment of the Eye.用于眼后段非感染性葡萄膜炎的新型眼内治疗方法。
Med Hypothesis Discov Innov Ophthalmol. 2013 Winter;2(4):113-20.
3
Cytokines and Biologics in non-infectious autoimmune uveitis: bench to bedside.细胞因子和生物制剂在非感染性自身免疫性葡萄膜炎中的应用：从基础到临床。
Indian J Ophthalmol. 2014 Jan;62(1):74-81. doi: 10.4103/0301-4738.126187.
4
The effectiveness and ineffectiveness of complex behavioral interventions: impact of treatment fidelity.复杂行为干预的有效性和无效性：治疗保真度的影响。
Contemp Clin Trials. 2014 Mar;37(2):234-41. doi: 10.1016/j.cct.2014.01.005. Epub 2014 Jan 24.
5
Definitions, variants, and causes of nonadherence with medication: a challenge for tailored interventions.药物治疗依从性的定义、变体及原因：定制干预措施面临的挑战
Patient Prefer Adherence. 2013 Jul 10;7:675-82. doi: 10.2147/PPA.S29549. Print 2013.
6
The standardization of uveitis nomenclature project: the future is here.葡萄膜炎命名标准化项目：未来已至。
JAMA Ophthalmol. 2013 Jun;131(6):787-9. doi: 10.1001/jamaophthalmol.2013.1596.
7
Review on the worldwide epidemiology of uveitis.葡萄膜炎全球流行病学综述。
Eur J Ophthalmol. 2013 Sep-Oct;23(5):705-17. doi: 10.5301/ejo.5000278. Epub 2013 May 3.
8
Smartphone medication adherence apps: potential benefits to patients and providers.智能手机用药依从性应用：对患者和提供者的潜在益处。
J Am Pharm Assoc (2003). 2013 Mar-Apr;53(2):172-81. doi: 10.1331/JAPhA.2013.12202.
9
Update on the principles and novel local and systemic therapies for the treatment of non-infectious uveitis.非感染性葡萄膜炎治疗的原则及新型局部和全身疗法的最新进展
Inflamm Allergy Drug Targets. 2013 Feb;12(1):38-45. doi: 10.2174/1871528111312010006.
10
[Duration of treatment with etanercept and motives for discontinuation in a cohort of patients with rheumatic disease].[依那西普治疗风湿性疾病患者队列的疗程及停药原因]
Reumatol Clin. 2011 Nov-Dec;7(6):385-8. doi: 10.1016/j.reuma.2011.06.005. Epub 2011 Oct 24.
Zotero 插件